Arabic Arabic English English French French German German
dark

Financial information in the Form S-1 registration statement and Change to Board of Directors

MaxCyte, Inc., a leading provider of platform technologies for cell engineering, announced the public filing of a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed dual-listing and public offering of shares of common stock on the Nasdaq Stock Market. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Acutus Medical, Inc. Announces Proposed Public Offering of Common Stock

Next Post

Veteran AI and ML Leader from LG Electronics and Bosch Joins H1 as SVP of Data Science and Machine Learning

Related Posts
Total
0
Share